Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | +0.66% | +11.68% | +73.86% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -41M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.72
x | P/E ratio 2025 * |
-5.16
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Atossa Therapeutics, Inc.
1 day | +0.66% | ||
1 week | +11.68% | ||
Current month | -15.00% | ||
1 month | -16.39% | ||
3 months | +86.59% | ||
6 months | +128.73% | ||
Current year | +73.86% |
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Heather Rees
DFI | Director of Finance/CFO | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Director/Board Member | 66 | 14-02-28 | |
H. Remmel
BRD | Director/Board Member | 72 | 12-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.53 | +0.66% | 900,111 |
24-04-25 | 1.52 | +1.33% | 854,598 |
24-04-24 | 1.5 | +0.67% | 2,338,056 |
24-04-23 | 1.49 | +4.93% | 1,219,031 |
24-04-22 | 1.42 | +3.65% | 1,020,568 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.86% | 192M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ATOS Stock